N4-acetylcytidine modification bridges metabolic reprogramming and immune evasion in cancer: mechanisms and therapeutic implications - Poll - MDSpire

N4-acetylcytidine modification bridges metabolic reprogramming and immune evasion in cancer: mechanisms and therapeutic implications

  • By

  • Ming-Zhu Jin

  • Wen Di

  • June 29, 2026

  • 0 min

Share

Original Source(s)

N4-acetylcytidine modification bridges metabolic reprogramming and immune evasion in cancer: mechanisms and therapeutic implications

  • by Ming-Zhu Jin, Wen Di

  • June 29, 2026

Related Content

Prehabilitation in cancer care: an evolving field

A systematic review and meta-analysis of the effects of walking training on cardiorespiratory fitness in cancer patients

Diagnostic accuracy of imaging modalities for primary small-bowel tumors: a systematic review and diagnostic test accuracy meta-analysis